Organisation paid for research Program year 2020 Source: CMS Open Payments

Allergy, Asthma & Sinus Center, SC

Neither a doctor nor a teaching hospital

Research payments

$305,459

26 payments

Through program year 2020, Allergy, Asthma & Sinus Center, SC is reported as receiving $305,459 in research payments, across 26 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$265,731	25
2019	Research	$39,728	1

Breakdown

Who paid Research payments · program years 2019–2020

Amphastar Pharmaceuticals, Inc. $217,918 2 payments
Teva Pharmaceuticals USA, Inc. $87,540 24 payments

Studies the money was for Research payments · program years 2019–2020

Phamacodynamic (PD) Bronchodilatation Bioequivalence (BE) Study of Albuterol Sulfate HFA MDI 90 mcg/inhalation in Asthma Patients $178,190 1 payment
A Randomized, Blinded, Parallel Group, Placebo-Controlled, Multiple Dose, Multicenter Study to Compare the Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent HFA 110 mcg, in Adult Subjects With Asthma $72,706 18 payments
Pharmacodynamic (PD) Bronchodilatation Bioequivalence (BE) Study of Albuterol Sulfate HFA MDI 90 mcg/inhalation in Asthma Patients $39,728 1 payment
A 16-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Proof-of-Concept Study to Evaluate the Efficacy and Safety of TEV-48574 in Adults With T2-low/Non-T2 Severe Uncontrolled Asthma $14,834 6 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.